Medifast (NYSE:MED) will be announcing its earnings results after the market closes on Thursday, February 25th. Analysts expect the company to announce earnings of $2.36 per share for the quarter. Investors interested in participating in the company’s conference call can do so using this link.
Shares of MED stock opened at $260.57 on Tuesday. The firm has a 50-day moving average of $236.58 and a 200-day moving average of $189.27. The company has a market cap of $3.07 billion, a P/E ratio of 32.61 and a beta of 1.52. Medifast has a one year low of $49.03 and a one year high of $279.46.
The company also recently announced a quarterly dividend, which was paid on Friday, February 5th. Stockholders of record on Tuesday, December 22nd were issued a $1.13 dividend. The ex-dividend date was Monday, December 21st. This represents a $4.52 annualized dividend and a dividend yield of 1.73%. Medifast’s dividend payout ratio is currently 75.84%.
In related news, Director Jeffrey J. Brown acquired 133 shares of the firm’s stock in a transaction that occurred on Friday, February 5th. The stock was acquired at an average price of $240.99 per share, for a total transaction of $32,051.67. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 4.00% of the company’s stock.
Medifast, Inc, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. It offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape for Life, and Flavors of Home brands.
Featured Story: Monthly Dividend Stocks Can Provide Solid Income
Receive News & Ratings for Medifast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medifast and related companies with MarketBeat.com's FREE daily email newsletter.